PS2:28 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events
P Budde, J Marte, H-D Zucht, S Bhandari, M Tuschen, P Schulz-Knappe, J Gulley, C Heery, R Madan, J Schlom
Lupus Science & Medicine Mar 2018, 5 (Suppl 1) A45-A46; DOI: 10.1136/lupus-2018-abstract.76